Press Releases

Congresswoman Rosa DeLauro (CT-03) today called on the U.S. Food and Drug Administration (FDA) to take immediate action in stopping the distribution of produce by the firms implicated in the recent deadly Salmonella outbreak linked to cucumbers grown in Mexico.

Today, U.S. Senator Chris Murphy (D-CT), U.S. Senator Richard Blumenthal (D-CT), U.S. Representative Rosa DeLauro (CT-03), and U.S. Representative Elizabeth Esty (CT-05) urged the CDC to consider purchasing an increased number of doses of the Flublok vaccine, which is manufactured by Protein Sciences in Meriden, Connecticut.

Today, Democratic Steering & Policy Committee Co-Chairs Congresswoman Rosa DeLauro (D-CT) and Congresswoman Donna F. Edwards (D-MD), and Congressman Dan Kildee (D-MI) sent a letter to Michigan Governor Rick Snyder inviting him to testify before House Democrats’ Steering & Policy Committee.

Today, Rep. Rosa DeLauro (D-CT), Rep. Norma J. Torres (D-CA), and Rep. Jared Polis (D-CO) were joined by thirty Members of Congress in sending a letter to Secretary of Homeland Security Jeh Johnson and Attorney General Loretta Lynch reiterating concerns about due process and the safety of recently deported Central American families.

Congresswomen Rosa DeLauro (CT-03) and Louise Slaughter (NY-25) today released the following statements on the U.S. Department of Agriculture’s Food Safety and Inspection Service’s finalization of new federal standards to reduce Salmonella and Campylobacter in ground chicken and turkey products, as well as in raw chicken breasts, legs, and wings.

Congresswoman Rosa DeLauro (CT-03) released the following statement on the Republicans’ attempt to override the President’s veto of the reconciliation bill that would repeal the Affordable Care Act (ACA) and defund Planned Parenthood.

Congresswoman Rosa DeLauro (CT-03) released the following statement on the President’s proposal for $1.1 billion in new funding to address the prescription opioid abuse and heroin use epidemic.

Congresswoman Rosa DeLauro (CT-03) today visited Arvinas, a New Haven pharmaceutical development company, to highlight the increase in funding for the National Institutes of Health (NIH) in the 2016 budget.